Extraocular movements were full with no ocular misalignment
What to expect when starting retatrutide
Our study, a prospective cohort study conducted in a real-world clinical setting, reflecting actual clinical practice and patient management, demonstrates that the use of GLP-1RAs in patients with T2D undergoing coronary stent implantation is associated with a significant reduction in major adverse cardiovascular events (MACEs)and coronary lesion progression
A licensed provider determines whether semaglutide is appropriate based on individual medical history and eligibility
Join the DSC Practitioner Membership today and get instant access to our full library of evidence-based handouts, templates, and counseling tools
Nov 12 2025;26(22)doi:10.3390/ijms262210947 Zheng SH, Chen XX, Chen Y, Wu ZC, Chen XQ, Li XL